Per Favore, prova con una nuova ricerca
L’obiettivo del fondo è la rivalutazione del capitale tramite investimenti globali in titoli azionari di società operanti nel settore sanitario e scientifico. Una parte rilevante del fondo sarà in genere investita in società statunitensi. Applicando un processo di selezione bottom-up, il team mira a individuare società leader di mercato che dispongano di attività di ricerca, gestione finanziaria e capacità di marketing di livellosuperiore.
Nome | Titolo | Dal | Fino a |
---|---|---|---|
John H. Fogarty | Senior Vice President | 2019 | Adesso |
Biografia | John H. Fogarty is a Senior Vice President and Portfolio Manager for US Growth Equities, a position he has held since 2009. He rejoined the firm in 2006 as a fundamental research analyst covering consumer-discretionary stocks in the US, having previously spent nearly three years as a hedge fund manager at Dialectic Capital Management and Vardon Partners. Fogarty began his career at AB in 1988, performing quantitative research, and joined the US Large Cap Growth team as a generalist and quantitative analyst in 1995. He became a portfolio manager in 1997. Fogarty holds a BA in history from Columbia University and is a CFA charterholder. Location: New York | ||
Vinay Thapar | Senior Vice President | 2013 | Adesso |
Biografia | Vinay Thapar is a Senior Vice President and Portfolio Manager for US Growth Equities. He is also a Senior Research Analyst, responsible for covering global healthcare. Prior to joining the firm in 2011, Thapar spent three years as a senior investment analyst covering global healthcare for two domestic investment funds at American Century Investments. Prior to that, he worked for eight years at Bear Stearns in the Biotech Equity Research Group, most recently as an associate director. Thapar holds a BA in biology from New York University and is a CFA charterholder. Location: New York | ||
John H. Fogarty | Senior Vice President | 2013 | 2018 |
Biografia | John H. Fogarty is a Senior Vice President and Portfolio Manager for US Growth Equities, a position he has held since 2009. He rejoined the firm in 2006 as a fundamental research analyst covering consumer-discretionary stocks in the US, having previously spent nearly three years as a hedge fund manager at Dialectic Capital Management and Vardon Partners. Fogarty began his career at AB in 1988, performing quantitative research, and joined the US Large Cap Growth team as a generalist and quantitative analyst in 1995. He became a portfolio manager in 1997. Fogarty holds a BA in history from Columbia University and is a CFA charterholder. Location: New York | ||
Bryce Hill | - | 2013 | 2015 |
Biografia | Mr. Hill is portfolio manager for the Disciplined Value strategy. He heads the global Health Care sector team and is a senior research analyst for the firm’s value/core equity strategies focusing on the health care and technology sectors. Mr. Hill is a CFA charterholder and holds an MBA from Columbia University and a BS in Business Administration, summa cum laude, from the University of Southern California. | ||
Tassos M. Stassopoulos | Senior Vice President | 2011 | 2013 |
Biografia | "Sector Head—Global/International Research Growth Tassos Stassopoulos is the Global/International Research Growth Sector Head for the consumer sector. He joined AllianceBernstein in 2007 as a research analyst covering retail, luxury, food and leisure/pubs in Europe. Stassopoulos was named the International Research Growth Sector Head for consumer in January 2009 and the Global Research Growth Sector Head for consumer in March 2011. Prior to joining the firm, Stassopoulos was a managing director at Credit Suisse for seven years, six of which he spent as a senior analyst and sector head for pan-European travel and leisure coverage. While there, he was twice ranked #1 in the Institutional Investor survey of analysts in his sector. In his last year at Credit Suisse, Stassopoulos was a portfolio manager at the firm’s internal hedge fund, Modal Capital. He also spent eight years as a management consultant at Arthur Andersen, where he specialized in lodging and gaming. Stassopoulos is a graduate of Cambridge University, St. John’s College, and a member of the Institute of Chartered Accountants. Location: London " | ||
Steven Nussbaum | - | 2007 | 2012 |
Biografia | Dr. Nussbaum manages the AllianceBernstein Healthcare Funds and is also the Healthcare Sector Head for Global Research Growth. Prior to joining Alliance Capital in 2002, Dr. Nussbaum worked as a Medical Products analyst at JP Morgan from 1999-2002. Prior to coming to Wall Street, he was an attending physician and a Clinical Assistant Professor of Radiology at Thomas Jefferson University Hospital in Philadelphia and before that he was an attending physician at Long Island Jewish Medical Center in New York. Dr. Nussbaum completed a radiology fellowship at Thomas Jefferson University Hospital, a radiology residency at Montefiore Medical Center in New York, and a medical internship at Danbury Hospital in Connecticut. He holds a BA from Harvard University, an MD from the Albert Einstein College of Medicine, and an MBA from the NYU Stern School of Business. | ||
Norman M. Fidel | Senior Vice President | 1995 | 2007 |
Biografia | Fidel is a senior vice president of AllianceBernstein. He joined the firm from Eberstadt Asset Management, where he served as a senior vice president and the director of research. Prior to that, he was a security analyst with Irving Trust Company. Fidel is a member of the New York Society of Security Analysts and the Health Industries Analyst Group of New York. |
Sei sicuro di voler bloccare %USER_NAME%?
Confermando il blocco tu e %USER_NAME% non potrete più vedere reciprocamente i vostri post su Investing.com.
%USER_NAME% è stato aggiunto correttamente alla lista di utenti bloccati
Poiché hai appena sbloccato questa persona, devi aspettare 48 ore prima di bloccarla nuovamente.
Considero questo commento come:
Grazie!
La tua segnalazione è stata inviata ai nostri moderatori che la esamineranno